Peterson, Craig A.

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

Gadde, K. M., Allison, D. B., Ryan, D. H., Peterson, C. A., Troupin, B., Schwiers, M. L., & Day, W. W. (2011) · The Lancet

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 1,064

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): A randomized, placebo-controlled, phase 3 extension study

Garvey, W. T., Ryan, D. H., Look, M., Gadde, K. M., Allison, D. B., Peterson, C. A., Schwiers, M., Day, W. W., & Bowden, C. H. (2012) · The American Journal of Clinical Nutrition

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 716

Controlled-release phentermine/topiramate in severely obese adults: A randomized controlled trial (EQUIP)

Allison, D. B., Gadde, K. M., Garvey, W. T., Peterson, C. A., Schwiers, M. L., Najarian, T., Tam, P. Y., Troupin, B., & Day, W. W. (2012) · Obesity

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 711

Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil

Padma-Nathan, H., Hellstrom, W. J. G., Kaiser, F. E., Labasky, R. F., Lue, T. F., Nolten, W. E., Norwood, P. C., Peterson, C. A., Shabsigh, R., Tam, P. Y., et al. (1997) · New England Journal of Medicine

Sexual function and dysfunction studiesUrological Disorders and Treatments

Cited by 574

Evaluation of phentermine and topiramate versus phentermine/topiramate extended‐release in obese adults

Aronne, L. J., Wadden, T. A., Peterson, C., Winslow, D., Odeh, S., & Gadde, K. M. (2013) · Obesity

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 274

Phentermine/Topiramate for the Treatment of Adolescent Obesity

Kelly, A. S., Bensignor, M. O., Hsia, D. S., Shoemaker, A. H., Shih, W., Peterson, C., & Varghese, S. T. (2022) · NEJM Evidence

Pharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Cited by 169

A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil

Hellstrom, W. J. G., Bennett, A. H., Gesundheit, N., Kaiser, F. E., Lue, T. F., Padma-Nathan, H., Peterson, C. A., Tam, P. Y., Todd, L. K., Varady, J. C., et al. (1996) · Urology

Sexual function and dysfunction studiesUrological Disorders and Treatments

Cited by 76

Cardiovascular Safety During and After Use of Phentermine and Topiramate

Ritchey, M. E., Harding, A., Hunter, S., Peterson, C., Sager, P. T., Kowey, P. R., Nguyen, L., Thomas, S., Cainzos-Achirica, M., Rothman, K. J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism

Pharmacology and Obesity TreatmentPharmacovigilance and Adverse Drug Reactions

Cited by 42

Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: what mediates improvement?

Kolotkin, R. L., Gadde, K. M., Peterson, C. A., & Crosby, R. D. (2016) · Quality of Life Research

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 24